First Light Asset Management as of Dec. 31, 2019
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 69 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Model N (MODN) | 8.8 | $69M | 2.0M | 35.07 | |
Oxford Immunotec Global | 8.7 | $68M | 4.1M | 16.60 | |
Repro-Med Systems (KRMD) | 6.0 | $47M | 7.2M | 6.53 | |
NeoGenomics (NEO) | 5.0 | $39M | 1.3M | 29.25 | |
Myokardia | 5.0 | $39M | 532k | 72.88 | |
Omnicell (OMCL) | 4.7 | $37M | 454k | 81.72 | |
AtriCure (ATRC) | 4.6 | $36M | 1.1M | 32.51 | |
Insmed (INSM) | 4.0 | $31M | 1.3M | 23.88 | |
Halozyme Therapeutics (HALO) | 3.9 | $30M | 1.7M | 17.73 | |
Intersect Ent | 3.8 | $30M | 1.2M | 24.90 | |
Immunomedics | 3.4 | $26M | 1.2M | 21.16 | |
Heron Therapeutics (HRTX) | 3.2 | $25M | 1.1M | 23.50 | |
Portola Pharmaceuticals | 3.1 | $24M | 1.0M | 23.88 | |
Seaspine Holdings | 2.8 | $22M | 1.8M | 12.01 | |
Codexis (CDXS) | 2.4 | $19M | 1.2M | 15.99 | |
Teva Pharmaceutical Industries (TEVA) | 2.1 | $16M | 1.7M | 9.80 | |
Tandem Diabetes Care (TNDM) | 2.0 | $16M | 269k | 59.61 | |
Ionis Pharmaceuticals (IONS) | 1.9 | $15M | 244k | 60.41 | |
Si-bone (SIBN) | 1.9 | $15M | 685k | 21.50 | |
Vapotherm | 1.8 | $14M | 1.1M | 12.16 | |
Xencor (XNCR) | 1.5 | $12M | 334k | 34.39 | |
Veracyte (VCYT) | 1.5 | $11M | 409k | 27.92 | |
Mylan Nv | 1.4 | $11M | 533k | 20.10 | |
Tabula Rasa Healthcare | 1.3 | $10M | 210k | 48.68 | |
Amarin Corporation (AMRN) | 1.3 | $9.8M | 458k | 21.44 | |
BioMarin Pharmaceutical (BMRN) | 1.1 | $8.6M | 102k | 84.55 | |
Arena Pharmaceuticals | 1.1 | $8.4M | 186k | 45.42 | |
Ultragenyx Pharmaceutical (RARE) | 0.9 | $7.5M | 174k | 42.71 | |
LHC | 0.9 | $7.3M | 53k | 137.76 | |
Trupanion (TRUP) | 0.9 | $7.2M | 192k | 37.46 | |
Bio-techne Corporation (TECH) | 0.8 | $6.2M | 28k | 219.51 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.7 | $5.8M | 27k | 218.95 | |
Orthopediatrics Corp. (KIDS) | 0.7 | $5.7M | 122k | 46.99 | |
Bluebird Bio (BLUE) | 0.7 | $5.7M | 65k | 87.76 | |
Cardiovascular Systems | 0.7 | $5.1M | 105k | 48.59 | |
Epizyme | 0.6 | $4.9M | 197k | 24.60 | |
Ligand Pharmaceuticals In (LGND) | 0.6 | $4.5M | 44k | 104.29 | |
Endologix | 0.6 | $4.6M | 2.9M | 1.58 | |
Quidel Corporation | 0.5 | $4.1M | 54k | 75.02 | |
Simulations Plus (SLP) | 0.5 | $3.6M | 125k | 29.07 | |
Alexion Pharmaceuticals | 0.4 | $2.8M | 26k | 108.16 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.3 | $2.6M | 21k | 120.53 | |
Invesco S&p Smallcap Health Etf (PSCH) | 0.3 | $2.2M | 17k | 129.25 | |
iShares Dow Jones US Medical Dev. (IHI) | 0.3 | $2.0M | 7.6k | 264.38 | |
Health Care SPDR (XLV) | 0.2 | $1.9M | 18k | 101.86 | |
LeMaitre Vascular (LMAT) | 0.2 | $1.7M | 49k | 35.96 | |
Global Blood Therapeutics In | 0.1 | $1.1M | 14k | 79.50 | |
Teligent | 0.1 | $719k | 1.7M | 0.43 | |
Bristol Myers Squibb (BMY) | 0.1 | $655k | 10k | 64.22 | |
Transmedics Group (TMDX) | 0.1 | $513k | 27k | 19.00 | |
Merck & Co (MRK) | 0.1 | $386k | 4.2k | 90.89 | |
Abbvie (ABBV) | 0.1 | $364k | 4.1k | 88.48 | |
Allergan | 0.1 | $412k | 2.2k | 191.01 | |
Health Catalyst (HCAT) | 0.1 | $385k | 11k | 34.68 | |
Johnson & Johnson (JNJ) | 0.0 | $315k | 2.2k | 145.77 | |
Pfizer (PFE) | 0.0 | $332k | 8.5k | 39.20 | |
Novartis (NVS) | 0.0 | $335k | 3.5k | 94.77 | |
Sanofi-Aventis SA (SNY) | 0.0 | $334k | 6.7k | 50.23 | |
Baxter International (BAX) | 0.0 | $272k | 3.3k | 83.49 | |
Amgen (AMGN) | 0.0 | $263k | 1.1k | 240.84 | |
UnitedHealth (UNH) | 0.0 | $203k | 692.00 | 293.35 | |
Agilent Technologies Inc C ommon (A) | 0.0 | $217k | 2.5k | 85.16 | |
Bio-Rad Laboratories (BIO) | 0.0 | $203k | 548.00 | 370.44 | |
Hill-Rom Holdings | 0.0 | $241k | 2.1k | 113.63 | |
Smith & Nephew (SNN) | 0.0 | $215k | 4.5k | 48.08 | |
Grifols S A Sponsored Adr R (GRFS) | 0.0 | $237k | 10k | 23.31 | |
Anthem (ELV) | 0.0 | $240k | 795.00 | 301.89 | |
Steris | 0.0 | $251k | 1.6k | 152.21 | |
Dynatronics | 0.0 | $105k | 126k | 0.83 |